Dr. Emile Sami Moukheiber, MD

Dr. Moukheiber practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Moukheiber's NPI, 1477803427, was assigned on September 18, 2012. Dr. Moukheiber holds Maryland license D82261.

Dr. Moukheiber's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Moukheiber's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Moukheiber is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Moukheiber to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moukheiber practices. Vendor and product names are available with a free account.

Neurology is Dr. Moukheiber's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Moukheiber is licensed in Maryland.

CMS data shows 724 Medicare services from Dr. Moukheiber across 17 procedure codes in 2024, for 232 Medicare patients. Medicare paid $52,572 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 232 Medicare patients who saw Dr. Moukheiber in 2024. The largest group is 65 to 74, with 124 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Moukheiber's median patient age at 74, with 42% women.

In 2024, Dr. Moukheiber wrote 612 Medicare Part D claims for 96 patients. 82% of them were for generic drugs. CMS names the drug for 516 of them, across 15 drugs with 11 or more claims each, at $198,512 in total drug cost. In 2023, CMS named 436 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Moukheiber for performance year 2024, reported as part of a group. CMS lists Dr. Moukheiber as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 18 papers to Dr. Moukheiber, published from 2017 to 2025. 2022 was the busiest year, with 4. The most frequent topics are Parkinson Disease, Blepharospasm and Dystonic Disorders. Dr. Moukheiber has published most often in Parkinsonism Relat Disord. Dr. Moukheiber's most frequent co-authors are Hyder A. Jinnah, MD, PhD, Alexander Pantelyat, MD and Cynthia L. Comella, MD.

CMS Open Payments shows 18 general payments to Dr. Moukheiber from 7 drug and device companies from 2016 to 2024. Grants make up the largest share, 94% of the total. Medtronic USA, Inc. paid the most, $26,274.